Luis M. Salmun

819 total citations
10 papers, 627 citations indexed

About

Luis M. Salmun is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Luis M. Salmun has authored 10 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology and Allergy. Recurrent topics in Luis M. Salmun's work include Asthma and respiratory diseases (9 papers), Allergic Rhinitis and Sensitization (5 papers) and Respiratory and Cough-Related Research (3 papers). Luis M. Salmun is often cited by papers focused on Asthma and respiratory diseases (9 papers), Allergic Rhinitis and Sensitization (5 papers) and Respiratory and Cough-Related Research (3 papers). Luis M. Salmun collaborates with scholars based in United States, Sweden and Argentina. Luis M. Salmun's co-authors include Andrea J. Pulkkinen, James E. Haddow, Glenn E. Palomaki, George J. Knight, Barbara A. Chilmonczyk, Louis M. Neveux, Richard Lorber, Lynda C. Schneider, Hermann M. Wolf and Işıl Barlan and has published in prestigious journals such as New England Journal of Medicine, Journal of Allergy and Clinical Immunology and Clinical Therapeutics.

In The Last Decade

Luis M. Salmun

9 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis M. Salmun United States 8 450 208 148 138 117 10 627
Alet H. Wijga Netherlands 11 453 1.0× 228 1.1× 179 1.2× 108 0.8× 61 0.5× 16 720
Marzia Pedreschi Italy 12 410 0.9× 418 2.0× 122 0.8× 139 1.0× 52 0.4× 22 685
B Burrows United States 12 745 1.7× 727 3.5× 168 1.1× 124 0.9× 87 0.7× 18 1.2k
Eamon Ellwood New Zealand 9 336 0.7× 192 0.9× 159 1.1× 57 0.4× 38 0.3× 16 516
M Vellutini Italy 11 294 0.7× 270 1.3× 113 0.8× 193 1.4× 78 0.7× 18 552
Paula Pallasaho Finland 15 458 1.0× 530 2.5× 200 1.4× 168 1.2× 45 0.4× 39 809
Charlotte E Rutter United Kingdom 8 251 0.6× 127 0.6× 134 0.9× 45 0.3× 31 0.3× 11 392
Paola Modena Italy 11 309 0.7× 229 1.1× 162 1.1× 95 0.7× 42 0.4× 17 470
C S Ulrik Denmark 19 1.1k 2.4× 954 4.6× 239 1.6× 40 0.3× 28 0.2× 29 1.2k
F.J. Rosser United States 10 305 0.7× 209 1.0× 33 0.2× 118 0.9× 71 0.6× 42 604

Countries citing papers authored by Luis M. Salmun

Since Specialization
Citations

This map shows the geographic impact of Luis M. Salmun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis M. Salmun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis M. Salmun more than expected).

Fields of papers citing papers by Luis M. Salmun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis M. Salmun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis M. Salmun. The network helps show where Luis M. Salmun may publish in the future.

Co-authorship network of co-authors of Luis M. Salmun

This figure shows the co-authorship network connecting the top 25 collaborators of Luis M. Salmun. A scholar is included among the top collaborators of Luis M. Salmun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis M. Salmun. Luis M. Salmun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Stettin, Glen, et al.. (2010). Intervention to Reduce Unnecessary Dispensing of Short-Acting β-Agonists in Patients with Asthma. Annals of Pharmacotherapy. 44(4). 623–629. 16 indexed citations
2.
Salmun, Luis M., et al.. (2006). Adherence with a Hand-Held Electronic Device versus Conventional Peak Expiratory Flow Rate Monitoring in Children with Asthma. Pediatric Asthma Allergy & Immunology. 19(2). 118–125. 2 indexed citations
3.
Borras, I., et al.. (2002). Open-Label Trial of High-Dose Intravenous Immunoglobulin in Patients with Severe Asthma. Pediatric Asthma Allergy & Immunology. 15(4). 187–194.
4.
Salmun, Luis M. & Richard Lorber. (2002). 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]. BMC Family Practice. 3(1). 14–14. 43 indexed citations
5.
Salmun, Luis M.. (2002). Antihistamines in late-phase clinical development for allergic disease. Expert Opinion on Investigational Drugs. 11(2). 259–273. 33 indexed citations
6.
Salmun, Luis M., et al.. (2000). Loratadine versus cetirizine: Assessment of somnolence and motivation during the workday. Clinical Therapeutics. 22(5). 573–582. 24 indexed citations
7.
Salmun, Luis M., Jerry Herron, Christopher Banfield, et al.. (2000). The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years. Clinical Therapeutics. 22(5). 613–621. 35 indexed citations
8.
Salmun, Luis M., et al.. (2000). 1123 Efficacy and safety of desloratadine in seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 105(1). S384–S385. 11 indexed citations
9.
Salmun, Luis M., Işıl Barlan, Hermann M. Wolf, et al.. (1999). Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: A double-blind, placebo-controlled, randomized trial. Journal of Allergy and Clinical Immunology. 103(5). 810–815. 52 indexed citations
10.
Chilmonczyk, Barbara A., Luis M. Salmun, Louis M. Neveux, et al.. (1993). Association between Exposure to Environmental Tobacco Smoke and Exacerbations of Asthma in Children. New England Journal of Medicine. 328(23). 1665–1669. 411 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026